Abstract
There has been great interest in ex vivo expansion of human long-term repopulating hematopoietic stem cells (LTR-HSC) for a variety of developing clinical applications including HSC transplantation, gene therapy, and production of mature blood cells in manufacturing. Because the development of HSC is thought to be regulated, at least in part, by interactions of cytokine receptor signals, many investigators used various combinations of cytokines that have been shown to act on primitive hematopoietic cells to obtain the optimal culture condition for HSC expansion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Luens, K. M., Travis, M. A., Chen, B. P., Hill, B. L., Scolly, R., and Murray, L. J. (1998) Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 91, 1206–1215.
Kobayashi, M., Laver, J. H., Kato, T., Miyazaki, H., and Ogawa, M. (1996) Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88, 429–436.
Sui, X., Tsuji, K., Tanaka, R., Tajima, S., Muraoka, K., Ebihara, Y., et al. (1995) gp130 and c-Kit signallings synergize for ex vivo expansion of human primitive hematopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 92, 2859–2863.
Yoshida, M., Tsuji, K., Ebihara, Y., Muraoka, K., Tanaka, R., Miyazaki, H., et al. (1996) Thrombopoietin alone stimulates the early proliferation and survival of human eryhtroid, myeloid and multipotential progenitors in serum-free culture. Br. J. Haematol. 98, 254–264.
Larochelle, A., Vormoor, J., Helmut, H., Wang, J. C., Bhatia, M., Lapidot, T., Moritz, T., et al. (1996) Identification of primitive human hematopoieitc cells capable of repopulating NOD/SCID mouse bone marrow: implications of gene therapy. Nat. Med. 2, 1329–1337.
Bhatia, M., Wang, J.C., Kapp, U., Bonnet, D., and Dick, J. E. (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA 94, 5320–5325.
Gan, O. I., Murdoch, B., Larochelle, A., and Dick, J. E. (1997) Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 90, 641–650.
Shultz, L. D., Schweitzer, P. A., Chritianson, S. W., Gott, B., Schweitzer, I. B., Tennet, B., et. al. (1997) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180–191.
Pflumio, F., Izac, B., Katz, A., Shultz, L. D., Vainchenker, W., and Coulombel, L. (1996) Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immnodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88, 3731–3740.
Ueda, T., Yoshida, M., Yoshino, H., Kobayashi, K., Kawahata, M., Ebihara, Y., et al. (2001) Hematopoietic capability of CD34+cord blood cells: a comparison with CD34+adult bone marrow cells. Int. J. Hematol. 73, 457–462.
Ueda, T., Tsuji, K., Yoshino, H., Ebihara, Y., Yagasaki, H., Hisakawa, H., et al. (2000) Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6 and soluble IL-6 receptor. J. Clin. Invest. 105, 1013–1021.
Ebihara, Y., Tsuji, K., Lyman, S. D., Sui, X., Yoshida, M., Muraoka, K., et al. (1997) Synergistic action of Flt3 and gp130 signalings in human hematopoiesis. Blood 90, 4363–4368.
Bhatia, M., Bonnet, D., Kapp, U., Wang, J. C. Y., Murdoch, B., and Dick, J. E. (1997) Quantitative analysis reveals expansion of human hematopoietic repopulat-ing cells after short-term ex vivo culture. J. Exp. Med. 186, 619–624.
Conneally, E., Cashman, J., Petzer, A., and Eaves, C. (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 94, 9836–9841.
Yoshino, H., Ueda, T., Kawahata, M., Kobayashi, K., Ebihara, Y., Manabe, A., et al. (2000) Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant 26, 1211–1216.
Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., et al. (1981) In vitro effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127, 34–38.
Ueda, T., Yoshino, H., Kobayashi, K., Kawahata, M., Ebihara, Y., Ito, M., et al. (2000) Hematopoietic repopulating ability of cord blood CD34+cells in NOD/ Shi-scid mice. Stem Cells 18, 204–213.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Tsuji, K., Ueda, T., Ebihara, Y. (2003). Cytokine-Mediated Expansion of Human NOD-SCID-Repopulating Cells. In: Körholz, D., Kiess, W. (eds) Cytokines and Colony Stimulating Factors. Methods in Molecular Biology, vol 215. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-345-3:387
Download citation
DOI: https://doi.org/10.1385/1-59259-345-3:387
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-1-58829-035-9
Online ISBN: 978-1-59259-345-3
eBook Packages: Springer Protocols